New Delhi:
Reshma Kewala Mani, Indian-origin CEO of US-based Wartax Pharmaceuticals, is named in the list of “100 most influential people” of 2025. Time magazine,
Who is Reshma Kevali Mani?
Born and brought to Mumbai, Ms. Kewal Mani was 11 years old when she moved to America with her family. She currently lives in Boston and has a twin son.
In 1998, Ms. Kewalmani completed the seven -year Liberal Arts/Medical Education Program of Boston University. After that, she enrolled in a Nephrology Fellowship at the Joint Program of Massachusetts General Hospital and Brigham and Women’s Hospital. In 2015, he obtained his degree from the general management program of Harvard Business School.
She started her career as a doctor and worked in famous hospitals such as Massachusetts General Hospital, Brigham and Women’s Hospitals, and Massachusetts came and also in ear inferring and MIT. Later, he entered the Biofarma sector and worked for more than 12 years.
Ms. Kewalmani began working for the vertex pharmaceuticals in 2017 and reached the post of Chief Medical Officer in 2018. In 2020, he was promoted to the post of President and CEO. She also currently works in the Wartax Board of Directors.
Since she has been on the rudder of cases in vertex, the company has increased extensively, developing new remedies, including Trichoca, which is a major drug to treat a severe genetic disease called cystic fibrosis. The company has developed VX-147, an experimental drug is being tested, which is due to a defective Apol1 gene for the treatment of a type of kidney disease.
Under his direction, the vertex was able to receive FDA approval for a CRISPR-based treatment for the first time, which corrects their DNA mutations of patients for the treatment of sickle cell disease and beta-thalassemia. In 2021, vertex was also ranked second among the top women -led businesses of the Commonwealth Institute at Massachusetts.
Ms. Kewalmani has also been awarded several awards, including the Golden Door Award and Hope Visionary Award of the International Institute of New England. He was also named New England in 2019 by Boston Business Journal Power 50 and New England Council by New England Council.